The Need for Additional Phenotyping When Defining Cardiogenic Shock. [Review] 

 -  2022 
<br/><br/><br/>English 
<br/><br/><label>ISSN: </label>1936-8798 
<br/><br/><label>Standard No.: </label>10.1016/j.jcin.2021.12.039 [doi] S1936-8798(21)02248-2 [pii] 
<br/><br/><label>Subjects--Topical Terms: </label><br/>*Heart Failure<br/>*Heart Failure<br/>*Heart-Assist Devices<br/>Humans<br/>Shock, Cardiogenic/di [Diagnosis]<br/>Shock, Cardiogenic/th [Therapy]<br/>Treatment Outcome<br/>Ventricular Function, Right
<br/><br/><label>Subjects--Geographic Terms: </label><br/>MedStar Heart & Vascular Institute<br/>MedStar Washington Hospital Center
<br/><br/><label>Index Terms--Occupation: </label><br/>Interventional Cardiology Fellowship
<br/><br/><label>Index Terms--Function: </label><br/>Journal Article<br/>Review